Filana Therapeutics (FLNA) Net Shares Issued and Repurchased (2012 - 2025)

Filana Therapeutics has reported Net Shares Issued and Repurchased for 14 years, with the latest figure at $1.7 million in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased fell 16.67% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $1.7 million, a 16.67% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 16.67% from the prior year.
• Net Shares Issued and Repurchased was $1.7 million for Q4 2025 at Filana Therapeutics, up from $1.7 million in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $2.1 million in Q4 2024, with the low at $1000.0 in Q1 2022.
• Average Net Shares Issued and Repurchased over 5 years is $781470.4, with a median of $531525.5 recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased tumbled 90.0% in 2022, then surged 31868.37% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $100000.0 in 2021, then grew by 4.0% to $104000.0 in 2022, then surged by 1017.31% to $1.2 million in 2023, then soared by 79.26% to $2.1 million in 2024, then fell by 16.67% to $1.7 million in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $1.7 million (Q4 2025), $1.7 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.